Mar­ket­ing pay­ments to can­cer doc­tors lead to more pre­scrip­tions but not bet­ter out­comes, NBER pa­per finds

Can­cer drug­mak­ers’ mar­ket­ing pay­ments to physi­cians do work, but they don’t im­prove pa­tient mor­tal­i­ty, ac­cord­ing to a new Na­tion­al Bu­reau of Eco­nom­ic Re­search work­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER